CN Patent

CN1247583C — 三唑并[4,5－d]嘧啶化合物的新晶形和非晶形

Assigned to AstraZeneca AB · Expires 2006-03-29 · 20y expired

What this patent protects

本发明提供式(I)化合物的新的形态。本发明涉及化合物(I)的形态，具体地说涉及晶形和非晶形，更具体地说涉及四种晶形和一种非晶形。本发明进一步涉及制备所述形态的方法、含有晶形和/或非晶形的所述化合物的药用组合物以及所述形态的治疗用途。

USPTO Abstract

本发明提供式(I)化合物的新的形态。本发明涉及化合物(I)的形态，具体地说涉及晶形和非晶形，更具体地说涉及四种晶形和一种非晶形。本发明进一步涉及制备所述形态的方法、含有晶形和/或非晶形的所述化合物的药用组合物以及所述形态的治疗用途。

Drugs covered by this patent

Patent Metadata

Patent number: CN1247583C
Jurisdiction: CN
Classification: —
Expires: 2006-03-29
Drug substance claim: No
Drug product claim: No
Assignee: AstraZeneca AB
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.